Triangle Business Journal featured the ITM’s CTSA consortium partner, Duke Clinical and Translational Science Institute, for its genetic test for newborns. The free test, which screens for spinal muscular atrophy and fragile X syndrome, has the potential to help as many as 120,000 North Carolina families with newborns per year.
“The conditions left out of standard newborn screening do not have enough evidence that early treatment changes outcomes, something necessary for a public health program that is done universally. Early Check researchers will provide information about whether some of these conditions are appropriate for newborn screening.
Lisa Gehtland, MD, physician and public health analyst at RTI and the project director
Source: Triangle Business Journal
